ETF Managers Group, LLC Sqz Biotechnologies CO Transaction History

ETF Managers Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.16 - $3.48 $565 - $911	-262 Reduced 2.95%	8,631 $20,000
Q2 2022 Aug 15, 2022	BUY	$2.77 - $5.0 $1,052 - $1,900	380 Added 4.46%	8,893 $28,000
Q1 2022 May 13, 2022	BUY	$4.01 - $10.42 $120 - $312	30 Added 0.35%	8,513 $40,000
Q4 2021 Feb 14, 2022	SELL	$8.93 - $14.85 $14,716 - $24,472	-1,648 Reduced 16.27%	8,483 $81,000
Q3 2021 Nov 15, 2021	BUY	$11.46 - $15.77 $21,854 - $30,073	1,907 Added 23.19%	10,131 $146,000
Q2 2021 Aug 16, 2021	SELL	$11.32 - $14.45 $3,486 - $4,450	-308 Reduced 3.61%	8,224 $114,000
Q1 2021 May 17, 2021	SELL	$12.07 - $29.9 $37,754 - $93,527	-3,128 Reduced 26.83%	8,532 $110,000
Q4 2020 Feb 16, 2021	BUY	$13.25 - $34.58 $154,495 - $403,202	11,660 New	11,660 $350,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.